
Tyzer Clinical Research Private Limited
About Tyzer Clinical Research Private Limited
Data last updated:
Tyzer Clinical Research Private Limited was a private limited company based in Kolhapur, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the scientific research segment of the research and development sector. It was incorporated on 19 July 2016.
The company was registered with the Registrar of Companies (ROC), Pune, under CIN U73100PN2016PTC165584.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Crom Contract Research Private Limited. It was led by directors Revati Krishnat Mane and Vijaykumar Shivajirao Patil.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at 620 E Ward Shashivihar 1st Lane Shahupuri Kolhapur, Maharashtra, India – 416001.
As per the financials filed for FY 2019, the company reported a revenue of ₹2.44 Lakh. For the same year it recorded a net profit of ₹25,900 (net margin 10.6%) and EBITDA of ₹47,400 (EBITDA margin 19.4%).
Company details
Contact details
Tyzer Clinical Research Private Limited's registered office is in Kolhapur, Maharashtra.
- Registered Address620 E Ward Shashivihar 1st Lane Shahupuri Kolhapur, Maharashtra, India – 416001
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tyzer Clinical Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Tyzer Clinical Research Private Limited, buy the company report.
Financials of Tyzer Clinical Research Private Limited
FY 2019 filings availableTyzer Clinical Research Private Limited reported revenue of ₹2.44 Lakh for FY 2019.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹47,400 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹25,900 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 19.4% | ||
| Net Profit Margin | 10.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Tyzer Clinical Research Private Limited, buy the company report.
Board of directors of Tyzer Clinical Research Private Limited
Tyzer Clinical Research has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Revati Krishnat Mane | Director | 07 Dec 2019 | 6 Years 11 Months | As last reported |
| Vijaykumar Shivajirao Patil | Director | 19 Jul 2016 | 10 Years 3 Months | As last reported |
Peer comparison
Tyzer Clinical Research Private Limited is compared with the 7 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alacris Medical Private Limited | ₹2.54 Lakh (FY 2021) | Halvad, Gujarat, India | ||||
| Territorial Prescience Research India Private Limited | ₹2.5 Lakh (FY 2018) | Bangalore, Karnataka, India | ||||
| Crystal Clear Pharma Consultancy Private Limited | ₹2.48 Lakh (FY 2019) | -39.0% | New Delhi, Delhi, India | |||
| Hopup Research Private Limited | ₹2.44 Lakh (FY 2019) | -90.0% | Delhi, India | |||
| Tyzer Clinical Research Private Limitedthis company | ₹2.44 Lakh (FY 2019) | ₹25,900 | 10.6% | Kolhapur, Maharashtra, India | ||
| Advanced Research Management Private Limited | ₹2.42 Lakh (FY 2025) | 44.0% | Bangalore, Karnataka, India | |||
| Scitel Scientific Solutions Private Limited | ₹2.41 Lakh (FY 2024) | -64.0% | Kayamkulam, Kerala, India | |||
| Sanity Life-Sciences Private Limited | ₹2.4 Lakh (FY 2025) | -71.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Tyzer Clinical Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Tyzer Clinical Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tyzer Clinical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Tyzer Clinical Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Tyzer Clinical Research Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Dhananjay Hari Lad ceased to be Director on 08 Dec 2019.
Frequently asked questions
Tyzer Clinical Research has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Tyzer Clinical Research was a private limited company based in Kolhapur, Maharashtra, India. The company worked in science research, within the research and development industry. It was incorporated on 19 July 2016 and is registered under CIN U73100PN2016PTC165584. The company has been struck off by the Registrar of Companies and is no longer operational.
Tyzer Clinical Research had 2 directors:
- Revati Krishnat Mane - Director
- Vijaykumar Shivajirao Patil - Director
The CIN (Corporate Identification Number) of Tyzer Clinical Research is U73100PN2016PTC165584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Tyzer Clinical Research is at 620 E Ward Shashivihar 1st Lane Shahupuri Kolhapur, Maharashtra, India – 416001.
Tyzer Clinical Research was incorporated on 19 July 2016. It is registered with the Registrar of Companies, Pune.
The latest financial statements of Tyzer Clinical Research on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
Tyzer Clinical Research operated in the research and development industry, in the science research segment. It worked in this industry before it was struck off.
The peers of Tyzer Clinical Research by revenue are Alacris Medical Private Limited, Territorial Prescience Research India Private Limited, Crystal Clear Pharma Consultancy Private Limited, Hopup Research Private Limited, Advanced Research Management Private Limited and 2 more, all in the same principal business activity (scientific research and development).
Dhananjay Hari Lad ceased to be Director on 08 Dec 2019. Revati Krishnat Mane was appointed as Director on 07 Dec 2019. Vijaykumar Shivajirao Patil was appointed as Director on 19 Jul 2016.
The compliance status of Tyzer Clinical Research is compliant as of 18 July 2026.

